[Anticoagulation and platelet aggregation inhibition : What needs to be considered in the ophthalmological practice]

Area of Science:

• Ophthalmology
• Internal Medicine
• Pharmacology

Background:

• Eye diseases requiring surgery are common in the elderly.
• Many elderly patients have systemic comorbidities requiring anticoagulation.
• Managing anticoagulation in patients undergoing eye surgery is complex.

Purpose of the Study:

• To provide an overview of pharmacological hemostasis options.
• To discuss the importance of anticoagulation management in internal medicine for ophthalmic surgery.
• To analyze literature on interrupting or altering anticoagulation for eye surgery.

Main Methods:

• Literature review of pharmacological hemostasis.
• Analysis of anticoagulation adjustment strategies.
• Discussion of drug options for influencing hemostasis.

Main Results:

• The number of anticoagulation options has increased with new drugs.
• Understanding hemostasis management is crucial for internal medicine.
• Literature analysis informs decisions on anticoagulation modification for eye surgery.

Conclusions:

• Pharmacological hemostasis management is essential for elderly patients undergoing eye surgery.
• Newer anticoagulation drugs require careful consideration.
• Evidence-based strategies are needed for safe perioperative anticoagulation management.